Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOIRC phase II trial of gene expression-guided first-line chemotherapy in advanced non-small cell lung cancer
2009-017094-38Phase 2Active
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Nov 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of gemcitabine, cisplatin, docetaxel and vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Primary endpoint: Objective response rate. Started Nov 2010; status: active.
02
Drugs
gemcitabinecisplatindocetaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2009-017094-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017094-38.